Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
Clinical trial NCT02797704 · TERMINATED
Trial details
- NCT number
- NCT02797704
- Sponsor
- Rabin Medical Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-02
- Primary completion
- 2019-09-04
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.